Renascience (TSE:4889) EV-to-FCF: (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
51 GF Score
Price 円1,230.00
GF Value 円305.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Renascience's Enterprise Value is 円15,145.76 Mil. Renascience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.00 Mil. Therefore, Renascience's EV-to-FCF for today is .

The historical rank and industry rank for Renascience's EV-to-FCF or its related term are showing as below:

TSE:4889' s EV-to-FCF Range Over the Past 10 Years
Min: -57.43   Med: 0   Max: 0
Current: -57.43

TSE:4889's EV-to-FCF is ranked worse than
100% of 408 companies
in the Medical Devices & Instruments industry
Industry Median: 24.4 vs TSE:4889: -57.43

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-02), Renascience's stock price is 円1230.00. Renascience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-24.080. Therefore, Renascience's PE Ratio (TTM) for today is At Loss.


Renascience  (TSE:4889) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Renascience's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1230.00/-24.080
=At Loss

Renascience's share price for today is 円1230.00.
Renascience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-24.080.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Renascience EV-to-FCF Related Terms


Renascience EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Renascience's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience EV-to-FCF Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial -15.03 -13.22 -13.67 -65.05 -67.68

Renascience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -67.68 0.00

TSE:4889 vs ABT, SYK, MDT: EV-to-FCF Comparison

For the Medical Devices subindustry, Renascience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renascience EV-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Renascience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Renascience's EV-to-FCF falls into.


TSE:4889
51GF Score
Renascience Inc TSE:4889
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience EV-to-FCF Calculation

Renascience's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=15145.759/0
=

Renascience's current Enterprise Value is 円15,145.76 Mil.
Renascience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,230.00 is trading 302.8% above its estimated GF Value™ of 円305.40. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • EV-to-FCF:
  • GF Value™: 円305.40 vs. price of 円1,230.00 (302.8% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
51GF Score

Get the complete analysis for TSE:4889

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,230.00
Price
円305.40
GF Value